Markets
Superstars
Analyst Estimates
Alerts
Screeners
Subscribe
Calendar
ETFs
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
Explore
FAQs
Widgets
More
Search stocks
IND
USA
USA
USA
×
Close
IND
USA
Stocks
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Stocks
Kymera Therapeutics Inc
Swot
Kymera Therapeutics Inc SWOT Analysis: Strengths, Weakness, Opportunity, and Threats
Kymera Therapeutics Inc has 5 Strengths, 18 Weaknesses, 1 Opportunities and 2 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential
Add SWOT widget to your site/app
Strengths
(5)
Weakness
(18)
Opportunity
(1)
Threats
(2)
Others
(0)
Significant (over 30%) distance from 52 week high
PEG lower than Industry PEG
Company with Low Debt
Stock with Low PE (PE < = 10)
Volume Shockers
Stocks with Quarter Change % less than Industry
Momentum Trap (DVM)
Bearish Stocks - Stocks with Medium to Low Trendlyne Momentum Score
Low DVM Stocks - Stocks to Exercise Caution On
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Risky Value (DVM)
Low durability companies
Inefficient use of shareholder funds - ROE declining in the last 2 years
Top Losers
Degrowth in Quarterly Revenue and Profit in Recent Results(YoY)
Low Piotroski Score : Companies with weak financials
Declining Net Cash Flow : Companies not able to generate net cash
Weak Momentum: Price below Short, Medium and Long Term Averages
Recent Results: Declining Operating Profit Margin and Net Profits (YoY)
Declining profits every quarter for the past 2 quarters
RSI indicating price weakness
Top Losers
Stocks Underperforming their Industry Price Change in the Quarter
Forecaster Consensus Estimates: Stocks with Strong Buy Calls from Analysts
Mutual Funds Decreased Shareholding in Past Month
MFs decreased their shareholding last quarter
